Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement
- 9 January 2020
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 382 (2), 130-139
- https://doi.org/10.1056/nejmoa1911426
Abstract
Subclinical leaflet thickening and reduced leaflet motion of bioprosthetic aortic valves have been documented by four-dimensional computed tomography (CT). Whether anticoagulation can reduce these phenomena after transcatheter aortic-valve replacement (TAVR) is not known.Keywords
Funding Information
- Bayer AG
- Janssen Pharmaceuticals Inc.
- ECRI, Rotterdam, the Netherlands
This publication has 29 references indexed in Scilit:
- Prosthetic Heart Valve ThrombosisJournal of the American College of Cardiology, 2016
- Course of early subclinical leaflet thrombosis after transcatheter aortic valve implantation with or without oral anticoagulationClinical Research in Cardiology, 2016
- Transcatheter Aortic Valve ThrombosisJournal of the American College of Cardiology, 2016
- Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO studyAmerican Heart Journal, 2016
- Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk PatientsThe New England Journal of Medicine, 2016
- Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valvesEuropean Heart Journal, 2015
- 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive SummaryJournal of the American College of Cardiology, 2014
- 2014 AHA/ACC guideline for the management of patients with valvular heart diseaseThe Journal of Thoracic and Cardiovascular Surgery, 2014
- Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk PatientsThe New England Journal of Medicine, 2011
- Interval estimation for the difference between independent proportions: comparison of eleven methodsStatistics in Medicine, 1998